Latest News and Press Releases
Want to stay updated on the latest news?
-
Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 17-12 / København, 3. oktober 2012 De foreløbige resultater fra det første stadie af fase II-delen af det kliniske fase I/II studie med belinostat i...
-
To NASDAQ OMX Copenhagen A/S Announcement no. 17-12 / Copenhagen, October 3, 2012 Initial results from the first stage of the phase II part of the phase I/II clinical trial of belinostat in...
-
Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 16-12 / København, Danmark 21. september 2012 Topotarget A/S har i dag meddelt, at det primære effektmål er opfyldt i det pivotale studie med...
-
To NASDAQ OMX Copenhagen A/S Announcement no. 16-12 / Copenhagen, Denmark September 21, 2012 Topotarget A/S today announced that the primary endpoint has been met for the belinostat pivotal...
-
To NASDAQ OMX Copenhagen A/S Announcement No. 15-12 / Copenhagen, September 17, 2012 Copenhagen, Denmark – September 17, 2012 – Today Topotarget A/S (NASDAQ OMX: TOPO) announced that clinical...
-
Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 15-12 / København, 17. september 2012 København, Danmark – 17. september 2012 – Topotarget A/S (NASDAQ OMX: TOPO) har i dag meddelt, at kliniske data...
-
To NASDAQ OMX Copenhagen A/S Announcement no. 14-12 / Copenhagen, August 30, 2012 Copenhagen, Denmark – August 30, 2012 – Topotarget A/S (NASDAQ OMX: TOPO) today announced the initiation of a...
-
Til NASDAQ OMX Copenhagen A/S Meddelelse Nr. 14-12 / København, 30. august 2012 København, Danmark – 30. august 2012 – Topotarget A/S (NASDAQ OMX: TOPO) har i dag annonceret indledningen af en...
-
To NASDAQ OMX Copenhagen A/S Announcement no. 13-12 / Copenhagen, August 29, 2012 Copenhagen, Denmark – August 29, 2012 – Today, Topotarget A/S (NASDAQ OMX: TOPO) announced that the Board of...
-
Til NASDAQ OMX Copenhagen A/S Meddelelse nr. 13-12 / København, 29. august 2012 København, Danmark – 29. august 2012 – Topotarget A/S (NASDAQ OMX: TOPO) har i dag meddelt, at bestyrelsen har...